British skincare specialist York Pharma is in fresh merger talks with a British company following end of its discussions with Uluru, a source familiar with the company's thinking said on Thursday.

York needs to find a funding solution by July 22 to repay 1 million pounds ($1.63 million) advanced by U.S.-based Uluru.

There is a lot of activity on the various options right now, the source said.

Analyst Jacob Plieth at Edison Investment Research said companies that might make a good fit would include fellow skincare specialist Sinclair Pharma, hospital medicines company IS Pharma and sexual health specialist Futura Medical.

York, Sinclair and IS Pharma would not comment, and Futura was not immediately available for comment.

($1 = 0.6153 pound)

(Editing by Dan Lalor)